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PSYCHOLOGICAL DISTRESS IN PATIENTS UNDERGOING
SURGERY FOR UROLOGICAL CANCER: A PROSPECTIVE
SINGLE CENTRE CROSS-SECTIONAL STUDYAntonio Luigi Pastore*, Giovanni Palleschi, Antonio Carbone, Latina,
Italy; Serena Maruccia, Milano, Italy; Ana Mir Bou, Nuria Camps Bell-
noch, Juan Palou, Barcelona, Spain
INTRODUCTION AND OBJECTIVES: Interest in disease-spe-
cific psychological well-being of patients with cancer has increased, and
it has been estimated that less than half of all cancer patients are
properly identified and treated for anxiety or depression. The aim of this
study was to evaluate psychological health assessment in oncological
patients admitted for surgery.
METHODS: We performed a cross-sectional study in consec-
utively enrolled patients with bladder, kidney or prostate cancer,
scheduled for surgery. Demographic data, socioeconomic status, edu-
cation level and diagnoses were recorded. We evaluated the level of
clinically meaningful depression and anxiety assessed by two tools: the
Hospital Anxiety and Depression Scale and the State-Trait Anxiety In-
ventory (STAI). In order to determine variables related to depression
and anxiety among the demographic variables, logistic regression an-
alyses were conducted, with p<0.05 considered as statistically
significant.
RESULTS: 207 patients completed the questionnaires and
were included in the study. The most frequent procedures were per-
formed for bladder tumours (60.4%), being transurethral resection the
most common type of surgery (52.7%) followed by radical prostatec-
tomy (24.6%). The mean STAI-state score was 19.3 (10.3), and the
mean STAI-trait score was 18.4 (11.9) points. Patients showed HADs
depression and anxiety scores of 3.3 (3) and 5.6 (3.3) points,
respectively. Female patients showed a higher level of anxiety and
STAI-trait compared to males.
CONCLUSIONS: Gender, tumour type and surgical approach
were significantly related to psychological distress in patients under-
going surgery for urological cancer. Females and patients with kidney
tumour undergoing radical nephrectomy presented higher levels of
anxiety.
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INTRODUCTION AND OBJECTIVES: Active surveillance in
localised prostate cancer is an accepted option in selected cases, but
some concerns still needs to be clarified. We pretend to evaluate
Health-Related Quality of Life (HRQoL), in a cross-sectional study, in
patients with localized prostate cancer undergoing active surveillance
(AS) compared with active treatments (radical prostatectomy, external-
beam radiotherapy, brachytherapy) and general population.
METHODS: Ninety-nine patients fulfilled the inclusion criteria.
This group was compared to different active treatments (n¼99 per
group) from the ’Spanish Multicentric Study of Clinically Localized
Prostate Cancer’ cohort using prostate-specific (Expanded Prostate
Cancer Index Composite [EPIC]) and generic (36-Item Short Form
Health Survey, version 2 [SF-36]) QoL instruments. SF-36 results were
also compared to US reference population.
RESULTS: Cross-section analysis was performed at 24 months
after initial therapy or AS beginning. AS group presented statistically
higher sexual scores [54.4 mean score (28.3 SD)] when compared to all
other active treatments and better urinary incontinence scores [87.4
(22.8 SD)] than radical prostatectomy group [65.8 (31.6 SD)]. Patients
undergoing AS were more likely to present significant urinary irritative/
obstructive symptoms compared to radical prostatectomy group. No
statistically significant differences were found among other domains.
Patients with localized prostate cancer, regardless of treatment applied,
presented slightly higher SF-36 physical and mental dimension scores
(except for radical prostatectomy) than US general population reference
norm (men aged 65-74).
CONCLUSIONS: AS may be a good treatment option for low or
intermediate risk prostate cancer since induces the least impact in QoL.
No significant differences were found on Physical and Mental Compo-
nent Summaries compared to general US population. This study pro-
vides cross-sectional information about AS impact on QoL.
Source of Funding: This work was supported by grants from
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PROSTATE SPECIFIC ANTIGEN AND HEALTH-RELATED
QUALITY-OF-LIFE OUTCOMES IN UNINSURED MEN WITH
PROSTATE CANCERAvi Baskin*, Joseph Shirk, Lorna Kwan, Karim Chamie, Los Angeles,
CA
INTRODUCTION AND OBJECTIVES: Prostate Specific Anti-
gen (PSA) continues to be a useful marker of risk strata and disease
progression for patients with prostate cancer. While there have been
multiple investigations into the relationship between PSA and mortality,
there is a dearth in the literature describing the association between
PSA and health-related quality-of-life (HRQOL) outcomes. In this study,
we hypothesize that PSA is inversely related with HRQOL in patients
with prostate cancer.
METHODS: Our cohort consisted of a prospective analysis of
men from a state-funded program that provides free prostate cancer
care to underinsured and uninsured low-income California residents
with prostate cancer. Highest pre-treatment PSA was our primary
exposure variable of interest. We created 4 strata: <10, 10-19.9, 20-
49.9 and 50 PSA. The primary outcome variables were HRQOL at
program enrollment using the RAND SF-12 to measure physical and
mental health, and the UCLA Prostate Cancer Index Short Form to
measure urinary, sexual and bowel habits in two domains: bother and
function. Controlling for demographic and clinical variables, we con-
ducted separate multivariable linear regression analysis for each quality
of life domain.
